Selank
Also known as: Selanc, TP-7, Tuftsin Analog
A synthetic anxiolytic peptide developed in Russia that provides anti-anxiety effects without sedation while also offering cognitive enhancement and immune modulation.
Half-Life
Short (minutes)
Typical Dose
200-400 mcg
Frequency
1-3x daily
Routes
Intranasal
Overview
Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is based on Tuftsin, a naturally occurring tetrapeptide that is part of the IgG antibody molecule and has immunomodulatory properties.
The Selank molecule combines Tuftsin (Thr-Lys-Pro-Arg) with a stabilizing Pro-Gly-Pro sequence, creating a peptide with both anxiolytic and nootropic properties.
In Russia, Selank is an approved medication for:
- Generalized anxiety disorder
- Neurasthenia
- Cognitive support
Key Characteristics
- Origin: Synthetic analog of endogenous Tuftsin
- Classification: Anxiolytic/nootropic peptide
- Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
- Approved Status: Prescription medication in Russia
- Unique Feature: Anxiolytic WITHOUT sedation or addiction potential
How Selank Differs from Benzodiazepines
| Feature | Selank | Benzodiazepines | |---------|--------|-----------------| | Sedation | None | Significant | | Addiction Potential | None | High | | Cognitive Effects | Enhancing | Impairing | | GABA Mechanism | Modulates, doesn't force | Direct agonist | | Withdrawal | None | Severe possible | | Daily Function | Preserved | Often impaired |
Mechanism
Selank operates through multiple distinct pathways, making it unique among anxiolytic agents.
Primary Mechanisms
1. GABA System Modulation
Unlike benzodiazepines, Selank modulates GABA gently:
- Affects GABA-A receptor expression
- Doesn't directly agonize receptors
- Restores GABA homeostasis
- Reduces anxiety without sedation
- No tolerance or dependence development
2. Serotonin and Dopamine Balance
Neurotransmitter modulation:
- Influences serotonin metabolism
- Modulates dopaminergic transmission
- Affects enkephalin processing
- Creates mood stabilization
- Without "high" or euphoria
3. BDNF Enhancement
Neurotrophic support:
- Increases Brain-Derived Neurotrophic Factor
- Supports neuroplasticity
- Enhances learning and memory
- Complements anxiolytic effects
- Long-term brain health support
4. Immune Modulation (Tuftsin Heritage)
From its Tuftsin origins:
- Enhances phagocyte activity
- Modulates immune response
- Potential antiviral properties
- Supports stress-related immunity
- Unique among anxiolytics
5. Inflammatory Cytokine Reduction
Anti-inflammatory in CNS:
- Reduces IL-6 expression
- Modulates inflammatory response
- May benefit neuroinflammatory conditions
- Supports overall brain health
Research
Research Note: Selank has extensive Russian clinical research and decades of medical use. Western research is limited but growing.
Anxiety Disorders (Approved Indication)
Russian Clinical Trials
Extensive clinical data shows:
- Significant reduction in anxiety scores
- Comparable efficacy to benzodiazepines
- No sedation or cognitive impairment
- No dependence development
- Sustained effects with regular use
Generalized Anxiety Disorder (GAD)
- Reduced Hamilton Anxiety scores
- Improved quality of life
- Better than placebo in controlled trials
- Effects build over days of use
Cognitive Enhancement
Memory and Learning
Research demonstrates:
- Enhanced memory consolidation
- Improved attention span
- Better cognitive flexibility
- Particularly under stress conditions
- Synergistic with reduced anxiety
Stress-Related Cognitive Decline
When stress impairs cognition:
- Selank preserves cognitive function
- Blocks stress-induced memory impairment
- Maintains performance under pressure
- Valuable for high-stress professions
Immune Function
Tuftsin-Derived Benefits
Unique immune properties:
- Enhanced natural killer cell activity
- Improved phagocyte function
- Potential antiviral effects
- May support recovery from illness
- Stress-immune axis modulation
2025 Research Updates
Recent studies explore:
- Immune support during chronic stress
- Potential adjunct for infections
- Stress-induced immunosuppression reversal
Depression (Adjunct Use)
While not primary indication:
- May help anxiety-related depression
- Enhances effects of antidepressants
- Improves stress resilience
- Being studied for combination therapy
Dosing
Disclaimer: Selank is not FDA-approved in the United States. It is approved in Russia for medical use. All dosing information is for research reference only.
Research Protocols
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| Anxiolytic | 200-400 mcg | 2-3x daily | 14-21 days |
| Cognitive Support | 200-300 mcg | 1-2x daily | 14-21 days |
| N-Acetyl Selank | 100-200 mcg | 1-2x daily | 14-21 days |
| Acute Anxiety | 400 mcg | As needed | Single use |
Forms Available
Standard Selank
- Original formulation
- Well-studied
- Moderate duration
N-Acetyl Selank (NASA)
- Acetylated version
- Enhanced stability
- Potentially more potent
- May have longer duration
N-Acetyl Selank Amidate
- Further modified
- Claimed enhanced penetration
- Used at lower doses
- Limited research comparison
Administration Notes
Intranasal (Standard)
- Most common route
- Excellent absorption
- Rapid onset (15-20 minutes)
- Spray or drops into nostril
- Alternate nostrils
Subcutaneous
- Alternative route
- More consistent absorption
- Some prefer for precise dosing
- Slightly slower onset
Timing
- Can be used throughout day
- Some prefer morning for all-day effect
- Can redose for acute anxiety
- Avoid very late evening (mild stimulation possible)
Cycling
While less necessary than with stimulants:
- Consider 2-3 weeks on, 1 week off
- Maintains optimal response
- Prevents any potential tolerance
- Russian protocols often continuous
Storage
- Refrigerate for long-term storage
- Room temperature okay for short periods
- Protect from light
- Nasal sprays: use within 2-4 weeks once opened
Pharmacokinetics
Absorption
- Intranasal: Rapid, within minutes
- Peak effects: 15-30 minutes
- Good CNS penetration
Distribution
- Crosses into brain
- Wide tissue distribution
- Concentrates at target sites
Metabolism
- Rapid enzymatic breakdown
- Pro-Gly-Pro provides some stability
- Metabolites may be active
Elimination
- Short half-life (minutes)
- Multiple daily dosing preferred
- No accumulation
Synergy & Stacking
Selank + Semax
The classic Russian nootropic combination:
- Selank: Anxiety reduction, calm focus
- Semax: Cognitive enhancement, BDNF
- Complementary mechanisms
- Can be used same day
- Stagger doses by 30+ minutes
Selank + Adaptogens
Stress management stack:
- Selank: Acute anxiolytic
- Rhodiola/Ashwagandha: Long-term adaptation
- Comprehensive stress support
Selank + Phenibut
Use with extreme caution:
- Both affect GABA system
- May enhance sedation
- Phenibut has addiction potential
- Generally not recommended
Safety
Known Side Effects
Common (mild)
- Nasal irritation (intranasal)
- Fatigue (rare, usually opposite)
- Headache (uncommon)
Very Rare
- Allergic reactions
- Nasal congestion with chronic use
Contraindications
Use with caution if:
- Pregnancy or breastfeeding
- Active infections (theoretical immune concern)
- Autoimmune conditions
Generally safe for:
- Most healthy adults
- Those seeking non-sedating anxiolytic
- Cognitive enhancement seekers
Safety Advantage: Unlike benzodiazepines, Selank has no addiction potential, no withdrawal syndrome, and no cognitive impairment. It's remarkably well-tolerated.
Drug Interactions
- Limited documented interactions
- May enhance effects of other anxiolytics
- Caution with immunosuppressants (immune modulation)
- Generally safe with most medications
Monitoring
Subjective Assessment
- Anxiety level tracking
- Cognitive performance
- Sleep quality (should improve or maintain)
- Mood monitoring
No Required Labs
- No specific blood tests required
- Consider immune markers if using for immune support
- General wellness labs as needed
Regulatory
Current Status
| Region | Status | |--------|--------| | Russia | Approved prescription medication | | United States | Not FDA-approved; research chemical | | European Union | Not approved; research use | | WADA | Not prohibited |
Legal Considerations
- Legal in most jurisdictions
- Not controlled substance
- Available from peptide suppliers
- Prescription only in Russia/CIS
Clinical Outlook
Selank represents an innovative approach to anxiety:
- Non-addictive anxiolytic is highly desirable
- Western interest growing
- Potential for formal clinical trials
- May influence future anxiolytic development
- Unique immune-anxiety connection